APA (7th ed.) Citation

Prochaska, J. H., Jünger, C., Schulz, A., Arnold, N., Müller, F., Heidorn, M. W., . . . Wild, P. S. (2023). Effects of empagliflozin on left ventricular diastolic function in addition to usual care in individuals with type 2 diabetes mellitus—results from the randomized, double-blind, placebo-controlled EmDia trial. Clinical research in cardiology, 112(7), 911-922. https://doi.org/10.1007/s00392-023-02164-w

Chicago Style (17th ed.) Citation

Prochaska, Jürgen H., et al. "Effects of Empagliflozin on Left Ventricular Diastolic Function in Addition to Usual Care in Individuals with Type 2 Diabetes Mellitus—results from the Randomized, Double-blind, Placebo-controlled EmDia Trial." Clinical Research in Cardiology 112, no. 7 (2023): 911-922. https://doi.org/10.1007/s00392-023-02164-w.

MLA (9th ed.) Citation

Prochaska, Jürgen H., et al. "Effects of Empagliflozin on Left Ventricular Diastolic Function in Addition to Usual Care in Individuals with Type 2 Diabetes Mellitus—results from the Randomized, Double-blind, Placebo-controlled EmDia Trial." Clinical Research in Cardiology, vol. 112, no. 7, 2023, pp. 911-922, https://doi.org/10.1007/s00392-023-02164-w.